FINWIRES · TerminalLIVE
FINWIRES

James Hardie Industries Under Law Firm Investigation Over Potential Disclosure Failures

-- James Hardie Industries (ASX:JHX) is being investigated by law firm Maurice Blackburn over potential disclosure failures ahead of the release of its fiscal first-quarter 2026 results, which precipitated a 34% decline in its Australia-listed shares over two trading days in August 2025, the law firm said.

Maurice Blackburn said the company in May 2025 guided for fiscal 2026 organic sales and earnings before interest, taxes, depreciation, and amortization growth across all regions, but in August 2025 reported weaker-than-expected quarterly results that included a fall in earnings and net sales.

"Our investigation concerns whether James Hardie engaged in misleading or deceptive conduct and/or breached its continuous disclosure obligations by failing to disclose material issues affecting its North American Fiber Cement segment," Maurice Blackburn said.

James Hardie Industries did not immediately respond to a request for comment from.

The company's shares were gaining more than 1% in recent Tuesday trade.

Related Articles

Australia

Tractor Supply Facing 'Modest Risk' to Fiscal 2026 Outlook, Morgan Stanley Says

Tractor Supply (TSCO) is facing a "modest risk" to its 2026 outlook amid traffic declines in Q1 and softer demand in the companion animal segment, Morgan Stanley said in a Wednesday note.The company reported fiscal Q1 earnings Tuesday of $0.31 per diluted share, down from $0.34 a year earlier, while net sales increased to $3.59 billion from $3.47 billion. According to Morgan Stanley, Tractor Supply projects fiscal 2026 comparable sales growth of 1% to 3% and $2.13 to $2.23 in adjusted EPS.Morgan Stanley estimated that the companion animal segment's comparable sales declined by about 3.5% in Q1. The segment could weigh on the company's 2026 outlook due to weaker demand as it is estimated to comprise low-20% of sales for the remainder of the year, the brokerage noted.There is also a risk that traffic remains flat-to-negative due to weaker consumer sentiment and increasing competition, among others, Morgan Stanley added.Morgan Stanley cut its price target on Tractor Supply to $45 from $57, with an equal-weight rating.Price: $39.15, Change: $-0.42, Percent Change: -1.06%

$TSCO
Australia

Piper Sandler Adjusts Boston Scientific Price Target to $90 From $105, Maintains Overweight Rating

Boston Scientific (BSX) has an average rating of Buy and mean price target of $96.45, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $64.59, Change: $+5.07, Percent Change: +8.52%

$BSX
Asia Markets

European Equities Traded in the US as American Depositary Receipts Edge Higher in Wednesday Trading

European equities traded in the US as American depositary receipts were higher late Wednesday morning, edging up 0.12% to 1,808.88 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by oil and gas firm Eni (E) and semiconductor firm Sequans Communications (SQNS), which rose 1.8% and 1.5% respectively. They were followed by 3D printer company Materialise (MTLS) and internet advertising firm Criteo (CRTO), which were up 1.1% and 0.7% respectively.The decliners from continental Europe were led by telecommunications company Nokia (NOK) and Ascendis Pharma (ASND), which fell 4.1% and 4% respectively. They were followed by medical device maker EDAP TMS (EDAP) and biotech firm Evaxion (EVAX), which were down 1.8% and 0.2% respectively.The gainers from the UK were led by mining company BHP Group (BHP) and pharmaceutical company Silence Therapeutics (SLN), which advanced 3% and 2.9% respectively. They were followed by utilities company National Grid (NGG) and telecommunications operator Vodafone (VOD), which increased 2.8% and 1.6% respectively.The decliners from the UK and Ireland were led by Akari Therapeutics (AKTX) and Biodexa Pharmaceuticals (BDRX), which dropped 3.8% and 3.4% respectively. They were followed by alcoholic beverage company Diageo (DEO) and hospitality company InterContinental Hotels Group (IHG), which lost 1.8% and 1.4% respectively.

$AKTX$ASND$BDRX$BHP$CRTO$DEO$E$EDAP$EVAX$IHG$MTLS$NGG$NOK$SLN$SQNS$VOD